BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23252446)

  • 21. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic infantile hemangiomas treated with oral propranolol--a case series.
    Mhanna A; Franklin WH; Mancini AJ
    Pediatr Dermatol; 2011; 28(1):39-45. PubMed ID: 21261702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Propranolol and infantile hemangiomas four years later: a systematic review.
    Marqueling AL; Oza V; Frieden IJ; Puttgen KB
    Pediatr Dermatol; 2013; 30(2):182-91. PubMed ID: 23405852
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Propranolol, a very promising treatment for ulceration in infantile hemangiomas: a study of 20 cases with matched historical controls.
    Hermans DJ; van Beynum IM; Schultze Kool LJ; van de Kerkhof PC; Wijnen MH; van der Vleuten CJ
    J Am Acad Dermatol; 2011 May; 64(5):833-8. PubMed ID: 21353329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient hypertriglyceridaemia associated with propranolol for treatment of infantile hemangioma.
    Farshchian M; Potts GA
    Australas J Dermatol; 2021 Nov; 62(4):e580-e581. PubMed ID: 34293182
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Propranolol for infantile haemangiomas: certain chances, potential risks.
    Hoeger PH
    Br J Dermatol; 2015 Jan; 172(1):3-4. PubMed ID: 25581581
    [No Abstract]   [Full Text] [Related]  

  • 27. Propranolol for infantile haemangiomas: initiating treatment on an outpatient basis.
    Zheng JW
    Cardiol Young; 2013 Oct; 23(5):780. PubMed ID: 23663321
    [No Abstract]   [Full Text] [Related]  

  • 28. Propranolol in the treatment of problematic infantile hemangioma: review of 35 consecutive patients from a vascular anomalies clinic.
    Bertrand J; Sammour R; McCuaig C; Dubois J; Hatami A; Ondrejchak S; Boutin C; Bortoluzzi P; Laberge LC; Powell J
    J Cutan Med Surg; 2012; 16(2):115-21. PubMed ID: 22513064
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Propranolol for infantile haemangiomas: a review.
    Starkey E; Shahidullah H
    Arch Dis Child; 2011 Sep; 96(9):890-3. PubMed ID: 21622997
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propranolol: useful therapeutic agent for the treatment of ulcerated infantile hemangiomas.
    Kim LHC; Hogeling M; Wargon O; Jiwane A; Adams S
    J Pediatr Surg; 2011 Apr; 46(4):759-763. PubMed ID: 21496551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial experiences with propranolol treatment of infantile hemangiomas: report of three cases.
    Halilbasic A; Hotic N; Husaric E; Rahmanovic E; Halilbasic M; Husaric S
    Med Arh; 2011; 65(6):380-2. PubMed ID: 22299307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In brief: oral propranolol infantile hemangiomas.
    Med Lett Drugs Ther; 2011 Oct; 53(1376):88. PubMed ID: 22033213
    [No Abstract]   [Full Text] [Related]  

  • 33. Ultrasound in assessing the efficacy of propranolol therapy for infantile hemangiomas.
    Shi H; Song H; Wang J; Xia L; Yang J; Shang Y; Zhou H
    Ultrasound Med Biol; 2014 Nov; 40(11):2622-9. PubMed ID: 25220276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A further experience of propranolol for severe infantile hemangiomas of the face: an observational study.
    Greco A; D'Erme AM; Zamma Gallarati B; Caputo R; de Martino M
    Dermatol Ther; 2014; 27(4):198-202. PubMed ID: 24548454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Propranolol for infantile hemangiomas with hyperinsulinemic hypoglycemia.
    Miyazaki T; Ozeki M; Sasai H; Ohnishi H
    Pediatr Int; 2021 Jun; 63(6):724-725. PubMed ID: 34042227
    [No Abstract]   [Full Text] [Related]  

  • 36. Retrospective analysis of beta-blocker instituted for treatment of hemangiomas (RABBIT study).
    Chu DH; Castelo-Soccio L; Wan J; Gelfand JM; Shaddy RE; Shah KN; Perman MJ; Treat JR; Yan AC
    Clin Pediatr (Phila); 2014 Oct; 53(11):1084-90. PubMed ID: 24849505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Propranolol for infantile haemangiomas: initiating treatment on an outpatient basis.
    Dyme JL; Thampan A; Han EJ; Nyirenda TL; Kotb ME; Shin HT
    Cardiol Young; 2012 Aug; 22(4):424-9. PubMed ID: 22166728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nadolol for Infantile Hemangiomas Previously Treated with Propranolol.
    Colmenero Sendra M; Del Boz González J; Segura Palacios JM; Valladares Millán I; Eguiluz Solana M; de Troya Martín M
    Actas Dermosifiliogr; 2024 Feb; 115(2):215-217. PubMed ID: 37356545
    [No Abstract]   [Full Text] [Related]  

  • 39. Surgical treatment outcomes of infantile hemangioma in children: Does prior medical treatment matter.
    Tangtatco JA; Freedman C; Phillips J; Pope E
    Pediatr Dermatol; 2018 Nov; 35(6):e418-e419. PubMed ID: 30187523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical propranolol therapy for infantile hemangiomas.
    Kunzi-Rapp K
    Pediatr Dermatol; 2012; 29(2):154-9. PubMed ID: 22141326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.